EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Genesystem Co's enterprise value is ₩32,887.6 Mil.
Genesystem Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-7,233.6 Mil. Therefore, Genesystem Co's EV-to-EBITDA for today is -4.55.
The historical rank and industry rank for Genesystem Co's EV-to-EBITDA or its related term are showing as below:
XKRX:363250'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -516.64 Med: -5.55 Max: 28.99
Current: -4.55
During the past 5 years, the highest EV-to-EBITDA of Genesystem Co was 28.99. The lowest was -516.64. And the median was -5.55.
XKRX:363250's EV-to-EBITDA is ranked worse than 100% of 114
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.35
vs XKRX:363250: -4.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Genesystem Co EV-to-EBITDA Historical Data
The historical data trend for Genesystem Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Genesystem Co's EV-to-EBITDA
For the Diagnostics & Research subindustry, Genesystem Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genesystem Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Genesystem Co's EV-to-EBITDA falls into.
Genesystem Co EV-to-EBITDA Calculation
Genesystem Co's EV-to-EBITDA for today is calculated as:
Genesystem Co's current Enterprise Value is ₩32,887.6 Mil.
Genesystem Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,233.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genesystem Co (XKRX:363250) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Genesystem Co's PE Ratio for today is calculated as:
Genesystem Co's share price for today is ₩6300.00.
Genesystem Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1138.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Genesystem Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:363250 has been successfully added to your 